Search

Sartorius Stedim Biotech.

Atidarymo kaina

SektoriusFinansų sektorius

199 -0.1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

192.6

Max

201

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.9M

93M

Pardavimai

4.2M

766M

P/E

Sektoriaus vid.

65.116

21.623

Pelnas, tenkantis vienai akcijai

1.25

Dividendų pajamingumas

0.35

Pelno marža

12.146

Darbuotojai

10,477

EBITDA

9.2M

240M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+18.24% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.35%

4.44%

Kitas uždarbis

2026-10-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.5B

19B

Ankstesnė atidarymo kaina

199.1

Ankstesnė uždarymo kaina

199

Naujienos nuotaikos

By Acuity

30%

70%

76 / 436 reitingas Finance

Sartorius Stedim Biotech. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-02 23:56; UTC

News

Entergy Corp settled its 2025 forward sale agreements, delivering over 11 million shares for $913 million. Shares are higher in after-market trading.

2026-09-02 23:51; UTC

News

Mitek Systems Inc. won first place in the Image category of the 2026 LivDet-Face competition, boosting shares significantly higher in after-hours trading.

2026-09-02 23:51; UTC

News
Social Media

Uber Technologies Inc. shares are higher in after-market hours following its abrupt exit from Nigeria and plans to lay off over 3,000 employees globally.

2026-09-02 23:51; UTC

News

Revolution Medicines shares rise in after-market trading following positive Phase 1/2 data on RASONQUE for advanced RAS mutant non-small cell lung cancer.

2026-09-02 23:51; UTC

News

NWPX Infrastructure acquires Serpentix Conveyor, enhancing its wastewater treatment portfolio. Shares are trading higher in after-market hours following the announcement.

2026-09-02 23:46; UTC

News
Social Media

Zoom Communications appoints Jeff Epstein to its Board of Directors, effective immediately. Shares are trading higher in after-market hours amid leadership changes.

2026-09-02 23:41; UTC

News
Correlated Moves

nCino Inc will participate in the Piper Sandler Growth Frontiers Conference on September 16, 2026. Shares are higher in after-market trading.

2026-09-02 23:36; UTC

News

Phreesia shares declined after reporting second-quarter revenues of $129.5 million, while earnings per share of $0.03 missed expectations of $0.09.

2026-09-02 23:31; UTC

News

Genworth Financial announced a $500 million share repurchase program, with shares trading higher in after-market hours.

2026-09-02 23:31; UTC

News

Capital Southwest Corp increased its credit facility commitments to $595 million and extended the maturity to September 2031. Shares are higher in after-market trading.

2026-09-02 23:26; UTC

News

Sprinklr Inc shares are higher in after-market trading ahead of a meeting with DA Davidson on September 10, signaling potential strategic discussions.

2026-09-02 23:16; UTC

News
Correlated Moves

Cytokinetics Inc shares are trading lower after-market following its investor conference announcements, with Ionis Pharmaceuticals' decline possibly impacting sentiment in the sector.

2026-09-02 23:06; UTC

News
Social Media

JPMorgan Chase has reduced financing to Jane Street amid competition in the bond market, with shares trading near unchanged in after-market hours.

2026-09-02 23:06; UTC

News

Johnson & Johnson will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. Shares are higher in after-market trading following the announcement.

2026-09-02 23:06; UTC

News
Correlated Moves

The U.S. Justice Department disrupted the Sality botnet, linked to cryptocurrency theft, contributing to CrowdStrike's higher shares in after-market hours.

2026-09-02 23:02; UTC

News
Social Media
Event

Broadcom Inc. shares fell in after-market trading following third-quarter earnings. Fourth-quarter revenue guidance of $34.8 billion missed consensus expectations of $35.05 billion.

2026-09-02 23:02; UTC

News

C3.ai Inc reported a fiscal Q1 net loss of $92.8 million and projected second-quarter revenue below expectations, contributing to a decline in after-market hours.

2026-09-02 23:02; UTC

News
Event
Social Media

Five Below Inc. shares rose in after-market trading after strong Q2 earnings and a $600 million share repurchase program announcement. Revenue guidance was also raised.

2026-09-02 23:02; UTC

News
Social Media

Ultragenyx Pharmaceutical shares are lower in after-market hours following the failure of its Phase 3 Aspire study for apazunersen in Angelman syndrome.

2026-09-02 23:02; UTC

News
Social Media

Snowflake Inc's stock rose in after-market trading following strong Q2 results, with adjusted EPS of $0.62 and revenue of $1.55 billion exceeding expectations.

2026-09-02 23:02; UTC

News

Kroger Co shares traded lower in after-market hours following the appointment of Mark Ibbotson as Executive Vice President and Chief Store Operations Officer.

2026-09-02 23:02; UTC

News
Social Media

NetApp Inc. shares declined in after-market trading following its earnings report, despite record revenues of $2.03 billion and raised fiscal year 2027 guidance.

2026-09-02 23:02; UTC

News

Ollie's Bargain Outlet updated its fiscal year 2026 EPS guidance, projecting $4.570 to $4.650, exceeding the consensus estimate. Shares are higher in after-market trading.

2026-09-02 23:01; UTC

News
Social Media

AeroVironment secures a $464.8 million U.S. Army contract for laser systems, boosting after-market shares amid positive revenue growth projections of $2.7 billion by 2028.

2026-09-02 23:01; UTC

News

Mirion Technologies shares rose in after-market trading following CFO Brian Schopfer's purchase of 20,000 shares for $312,000, increasing his total ownership to 1.33 million shares.

2026-09-02 23:01; UTC

News

Matrix Service Co's stock is lower in after-market hours following a fourth-quarter earnings miss, with adjusted EPS at $0.16 against a $0.20 estimate.

2026-09-02 23:01; UTC

News

Argan Inc reported record revenue of $384 million and net income of $53.3 million in Q2, driving shares sharply higher in after-market hours.

2026-09-02 23:01; UTC

News
Social Media
Event

PVH Corp reported second-quarter adjusted EPS of $3.70, exceeding expectations. Shares are trading higher in after-market hours following the earnings announcement.

2026-09-02 23:01; UTC

News
Social Media

Methode Electronics reported a wider net loss of $11.4 million for Q1 fiscal 2027, leading shares to trade lower in after-market hours.

2026-09-02 23:01; UTC

News
Event
Social Media

Tillys Inc shares rose in after-hours trading following strong Q2 results, with EPS of $0.27 surpassing estimates and revenue of $163.5 million.

Akcijų palyginimas

Kainos pokytis

Sartorius Stedim Biotech. Prognozė

Kainos tikslas

By TipRanks

18.24% į viršų

12 mėnesių prognozė

Vidutinis 234 EUR  18.24%

Aukščiausias 260 EUR

Žemiausias 210 EUR

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sartorius Stedim Biotech. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

5

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

76 / 436 reitingas Finansų sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat